Insulin resistance has been described as a possible underlying link for the clustering of Type 2 diabetes mellitus, hypertension, obesity, and dyslipidemia, known as the metabolic syndrome. Mutations within the insulin receptor have been associated with hypertension in some white and Oriental populations.
fragment-length polymorphism (RFLP) major allele (7.0 kb) has been reported in Australian white hypertensives when compared with normotensive subjects. [12] [13] [14] Although there was no significant difference in blood pressure between the alleles, there was a quantitative change in systolic blood pressure (SBP) levels between the genotypes. However, in the same study there was no association between a microsatellite polymorphism (located at a site in intron 2, close to exon 3) of the insulin receptor with blood pressure. 13 In the same population, there was a tendency towards an increased prevalence of the N1 allele of the NsiI RFLP located in exon 8 in hypertensives, compared with normotensives. 15 These authors also reported a weak association between this allele and angiotensinogen levels and significant increases in the frequency of this allele in their normolipidemic hypertensives when compared with normolipidemic normotensives and also between the lean hypertensive and normotensive subjects. 15 The P1 allele and homozygous genotype frequencies of a PstI RFLP were higher in hypertensive Polish subjects when compared with normotensive subjects. 16 However, not all associations between the insulin receptor and hypertension in whites have been positive. 17 There is also evidence to support a relationship between the insulin receptor and blood pressure in Oriental populations, with an increase in the frequency of the microsatellite polymorphism homozygote genotype of the common C allele in Japanese hyperinsulinemic hypertensives compared to normotensive controls. 18, 19 Furthermore, in Chinese, in a small study of 46 hypertensive and 49 normotensive subjects, there was a higher frequency of the G1040A allele, found in exon 17, in the hypertensives. 20 In our large study of 933 Hong Kong Chinese with various aspects of the metabolic syndrome, we investigated the insulin receptor gene NsiI RFLP for a possible association with this clustering of these disorders and the associated biochemical and anthropometric abnormalities.
MATERIALS AND METHODS
The Clinical Research Ethics Committee of the Chinese University of Hong Kong approved the study protocol. All 933 unrelated subjects gave written, informed consent. They were of Han Chinese origin, without any known ancestors of other ethnic origin, and were living in the Hong Kong Special Administrative Region of China at the time of the study. The catchment area of the Prince of Wales Hospital has only been developed since the 1960's, and serves a population of more than 1 million. The majority of its inhabitants are a typical socioeconomic representation of first-or second-generation migrants from Southern China now living in a Westernized environment.
Subjects were recruited from the medical outpatient clinics at the Prince of Wales Hospital. Seated blood pressure, and anthropometric and plasma biochemical parameters, after an overnight fast, were measured. The anthropometric parameters required to calculate the body mass index (BMI), waist-to-height ratio (WHtR), and waist-to-hip ratio (WHR) parameters were measured. Skinfold thickness measurements were taken at the triceps, biceps, iliac crest, and subscapular sites, using digital callipers (Skyndex electronic body fat calculator system, Caldwell Justiss, Fayetteville, AR), from which the percentage body fat was derived. 21 Subjects with impaired fasting glucose (IFG) and diabetes were diagnosed based on fasting plasma glucose (FPG) levels. FPG Ͻ 6.0 mmol/L was considered a normal glucose tolerance, a FPG of 6.0 to 7.0 mmol/L was considered IFG, and Ն 7.0 mmol/L was indicative of diabetes. 22 If the subjects had no diabetes-related complaints, then two elevated FPG readings were required for diagnosis. However, if the subject was symptomatic, a single elevated reading was sufficient. In subjects with equivocal plasma glucose levels who underwent a 75-g oral glucose tolerance test, a 2-h postglucose level of 7.8 to 11.1 mmol/L was considered indicative of impaired glucose tolerance (IGT). 22 In this study, subjects with IFG, IGT, and Type 2 diabetes were grouped together and considered to have glucose intolerance (GIT), of whom 95.9% had Type 2 diabetes. The index of insulin resistance we used is equivalent to that derived from the homeostasis model assessment (HOMA). 23 However, the relatively complex equation generated by this model (ie, insulin resistance ϭ insulin/[22.5e
Ϫ1n glucose ]) can be rearranged to the conceptually simpler fasting insulinglucose product (FIGP) divided by 22.5 (ie, insulin ϫ glucose/22.5). However, so that our data can be compared with those in previous publications and in other ethnic groups, we have divided our FIGP values by 22.5 to give the adjusted FIGPa parameter. As it is the product of pmol/L and mmol/L, we have omitted its units. The HOMA-derived index has been shown to correlate well with the results of the euglycemic hyperinsulinemic clamp in population-based studies. 3, 24 Subjects were defined as hypertensive if, after 5 min rest, their seated SBP was Ն 140 mm Hg and/or diastolic blood pressure (DBP) was Ն 90 mm Hg on at least two occasions while not taking antihypertensive treatment (after a 4-week washout period). 25 A mean of three readings taken 1 min apart was used. No subjects had a history of significant renal, hepatic, or cardiac disease. Normotensive (SBP was Ͻ 140 mm Hg and DBP was Ͻ 90 mm Hg) nondiabetic (FPG Ͻ 6.1 mmol/L) controls were recruited from hospital staff and their friends.
Obesity was defined as a BMI of Ն 25.0 kg/m 2 or Ն 27.0 kg/m 2 and/or WHR Ն 0.85 or Ն 0.90 in women and men, respectively. 22 Dyslipidemia was classified as either fasting plasma total cholesterol Ն 6.2 mmol/L or between 5.2 and 6.2 mmol/L, with the total cholesterol: HDL-cholesterol ratio being Ն 5.0, and/or fasting plasma triglycerides Ն 2.3 mmol/ L. 26, 27 The subjects were classified as controls or into seven nonoverlapping groups based on whether they had one of the three conditions-GIT, hypertension, or dyslipidemia-alone or in the various possible combinations (Table 1) . Additionally, overlapping groups of subjects, classified as having GIT, hypertension, dyslipidemia, or obesity according to the above-mentioned criteria, but also containing subjects with varying degrees of the other parameters were examined. As these metabolic derangements often occur together in the same patient, the combined numbers in these groups therefore exceeded 933.
Biochemical Analyses Fasting plasma samples were taken for measurement of electrolytes, urate, lipids (triglycerides, total cholesterol LDL-cholesterol, and HDL-cholesterol), and glucose. Plasma electrolytes were measured by ion-selective electrodes on a parallel multichannel analyzer (DuPont medical products, Newark, DE). Creatinine was measured using the Jaffe method on a Beckman Astra-8 Chemistry analyzer (Beckman, Brea, CA). Urate measurement, based on the uricase method, was performed using the Dade Dimension clinical chemistry system (Dade International Inc, Deerfield, IL). Plasma glucose was measured using a standard glucose oxidase method and total HbA 1c by electrophoresis (Ciba Corning Diagnostics, Palo Alto, CA; normal range: 6.5-8.5%). Insulin was measured in a 96-well microtiter plate enzyme-linked immunosorbent assay (ELISA) system (Dako Diagnostics Ltd, Ely, UK). Plasma total cholesterol and triglycerides were measured enzymatically (Centrichem Chemistry System, Baker Instruments. Co., Allentown, PA). The long-term imprecision of the assay was 3% at 3.3 mmol/L and 2.2% at 6.8 mmol/L for total cholesterol and 6.9% at 1.02 mmol/L and 4.6% at 2.18 mmol/L for triglycerides. HDL-cholesterol was determined after fractional precipitation with dextran sulphate-MgCl 2 , and LDL-cholesterol was calculated using Friedewald's formula.
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Insulin Receptor Gene A6224G Polymorphism The silent mutation in exon 8 of the insulin receptor gene at alanine 523 results in an A-to-G transition at nucleotide 6224 introducing an NsiI restriction site. 29, 30 Schrader et al described a polymerase chain reaction (PCR)-based RFLP method to examine this polymorphic site. 15 Approximately 1 ng of genomic DNA was added to 10 L of the PCR master mix (10 mmol/L Tris-HCl, 4 mmol/L MgCl 2 , 50 mmol/L KCl, pH 8.3, 0.1 mmol/L dNTP, 0.3 mol/L each primer (5Ј-CGG TCT TGT AAG GGT AAC TG-3Ј and 5Ј-GAA TTC ACA TTC CCA AGA CA-3Ј), 1 U Taq polymerase per sample). DNA amplification was performed in a thermocycler with 30 cycles of 95°C, 55°C, and 72°C for 1 min each. The 324-base pair (bp) amplification product was then digested with 2.5 U NsiI (Promega Corporation, Madison, WI) at 37°C for 4 to 5 h. The N1 or A allele lacks the restriction site, but the PCR product containing the mutant G or N2 allele was cleaved to a 239-bp and an 85-bp fragment.
Statistical Analyses Data from normally distributed parameters are presented as mean Ϯ SD, whereas skewed data were logarithmically transformed and expressed as geometric mean with 95% confidence intervals. Differences in the biochemical and anthropometric markers between cohorts were compared using the Student's t test. The Statistics Package for Social Sciences (SPSS for Windows, version 7.5.1, 1996, SPSS Inc, Chicago, IL) was used for the analyses.
Stepwise multiple regression analysis was also used to determine significant independent predictors of SBP and DBP. The variables included in the analyses were linearly related to the dependent variable. P Ͼ .1 was used as the level of rejection from the model. The subjects were coded 0, 1, and 2 for N1N1, N1N2, and N2N2 genotypes and 0 and 1 for male and female, respectively. Age was also included in the analysis. The appropriateness of the regression models was judged from the Durbin-Watson statistic (testing for serial correlation of adjacent error terms) and partial plots of the residuals. The tolerance and variance inflation factors (VIF) were taken as measures of collinearity, low tolerance and high VIF being signs of collinearity that indicate that a variable should not be included in the model.
RESULTS
The Chinese subjects with any aspect of the metabolic syndrome had increased adiposity, higher blood pressure (Table 2) , an adverse atherogenic lipid profile (lower HDL-cholesterol and higher total and LDLcholesterol and triglycerides), and increased FPG, when compared with the control population ( Table 3) . The insulin receptor gene NsiI RFLP allele and genotype distribution in the cohorts is described in Table 1 . The prevalences of the mutant N1 allele and N1N1 genotype were 74.4% and 55.8%, respectively, in the whole population. The genotype frequency distributions of this polymorphism were in Hardy-Weinberg equilibrium in the overall population and in each of the cohorts examined. No differences were observed in the genotype and allele frequency distributions between the control group and the nonoverlapping groups with GIT, hypertension, or dyslipidemia alone or in combination (Table 1) . Furthermore, the overlapping groups, including the obese group, also did not differ in genotype or allele frequency from the controls. One-way analysis of variance identified a possible relationship between this polymorphism and DBP in the total population, P ϭ .069. Furthermore, when the difference in DBP between the homozygous genotypes was examined using Student's t test, the DBP was significantly higher in subjects carrying the N1N1 genotype in both the total population (80 Ϯ 13 v 76 Ϯ 12 mm Hg, P ϭ .038) and subjects with glucose intolerance (80 Ϯ 12 v 76 Ϯ 10 mm Hg, P ϭ .048). Despite a similar small difference in DBP between glucosetolerant subjects (80 Ϯ 15 v 77 Ϯ 14 mm Hg) for those carrying the N1N1 and N2N2 genotypes, the difference did not reach significance.
Using stepwise multiple regression as described here, the insulin receptor NsiI polymorphism was found to be an independent predictor of DBP in this Chinese population, as were age, gender, and waist circumference (DBP ϭ 0.25 ϫ age ϩ 0.43 ϫ waist Ϫ 2.12 ϫ gender Ϫ 1.62 ϫ INSR genotype ϩ 45.0, F ϭ 63.4, R 2 ϭ 0.25, P Ͻ .001 for the model and P ϭ .018 for the genotype; Table 4 ). The high correlation with waist circumference meant BMI was excluded from the model, despite a strong correlation with DBP (r ϭ 0.29). This was also found in the regression analyses with SBP as the dependent variable, and, despite a strong correlation with SBP (r ϭ 0.21), of the anthro- pometric parameters only waist circumference remained in the model (Table 4) . Age was an independent predictor of SBP; however, gender and the insulin receptor genotypes were excluded. In none of the analyses was the insulin receptor polymorphism associated with SBP.
DISCUSSION
Adoption of modern Westernized lifestyles with highcalorie and high-fat diets and limited physical activity has led to rapidly increasing prevalence rates of the metabolic syndrome in Asian countries experiencing socioeconomic changes. 8, 31, 32 As expected, Chinese subjects exhibiting various aspects of the metabolic syndrome showed increased adiposity, particularly central, elevated blood pressure, an adverse atherogenic lipid profile, and reduced glucose tolerance when compared with the control populations in this study (Tables 1, 2 ). Similar findings have also been reported in other cohorts of Hong Kong Chinese subjects. 8, 33 In this study, both BMI and waist circumference strongly correlated with SBP and DBP. However, because of the high degree of correlation between BMI and waist circumference, BMI was excluded as an independent predictor of both SBP and DBP given the stronger relationship between waist circumference and blood pressure (Table 4) . When all confounding variables were controlled, central adiposity, as reflected in waist circumference, was found to be a major predictor of blood pressure in this Chinese population.
Within a population, genetic factors may determine those individuals predisposed to develop the various components of the metabolic syndrome. 34 -36 Mutations in the insulin receptor have been related to insulin-resistant states, a possible underlying link for the development of the metabolic syndrome. [1] [2] [3] [4] Although these states are often severe, 37, 38 other mutations may have less severe consequences, such as being associated with blood pressure in white populations. [12] [13] [14] [15] [16] 39 In white populations, insulin resistance has been associated with the pathogenesis of hypertension, 5, 6 and mutations in the insulin receptor are possible reasons for this relationship.
14 In our population of 933 Hong Kong Chinese, the NsiI RFLP was found to be an independent predictor of DBP, but not SBP. In the total population there was a tendency for the genotypes to be associated with DBP. Furthermore, those subjects carrying the N1N1 genotype were found to have significantly higher mean DBP than those with the N2N2 genotype. Schrader et al also described an association between this polymorphism and blood pressure, with the N1 allele also associated with higher blood pressure. As the A6224G polymorphism is silent, the relationship with DBP identified in this study must be mediated by other mutations within the insulin receptor or in neighboring genes with which the polymorphism is in linkage disequilibrium. As this is a nonfunctional marker, a lack of complete linkage disequilibrium may explain why, despite the relationship between the polymorphism and DBP, the frequencies of the NsiI genotypes were similar between the normotensive and hypertensive groups. Furthermore, this polymorphism accounts for a small, but significant, proportion of the DBP variance. It is likely that several such polymorphisms contribute collectively to produce a genetic background that interacts with environmental factors to cause hypertension. As such permissive genetic backgrounds are likely to be heterogeneous, it is questionable whether differences in the genotype distribution of genes that have a small contribution to blood pressure will be detected between the hypertensive and normotensive groups. However, in contrast to the current study, Schrader et al also described that the N1 allele was more prevalent in white hypertensives than in normotensives, particularly those who were not obese or dyslipidemic. 15 In white populations, the relationship between insulin resistance and blood pressure may be more evident than in equivalent Chinese populations and as such may account for a larger proportion of the blood pressure variance and hence may allow identification of differences in genotype distribution.
There is evidence to support the involvement of insulin resistance in the pathogenesis of hypertension in Oriental populations, particularly in the Japanese. [7] [8] [9] [10] [11] There is also evidence that the insulin receptor polymorphisms are associated with blood pressure in these populations. 18 -20 In Hong Kong Chinese, although a positive relationship between fasting plasma insulin and blood pressure has been previously described, much of the variance in insulin levels was attributed to obesity. 8 The weak relationship between insulin resistance and blood pressure in our population and the lack of association between insulin resistance and the insulin receptor polymorphism suggest that insulin resistance may not be the mechanism through which the receptor influences DBP. These findings corroborate those previously reported in whites describing a relationship between hypertension and this polymorphism 15 and other insulin receptor polymorphisms. [12] [13] [14] 16 In conclusion, we have evidence showing that the insulin receptor gene NsiI RFLP is associated with diastolic blood pressure in Hong Kong Chinese subjects with varying aspects of the metabolic syndrome. Although prospective and functional studies are required to elucidate these relationships more clearly, it is plausible that this gene may interact with other genetic and environmental factors to modulate diastolic blood pressure.
